301257 普蕊斯
午间休市 02-09 11:30:00
资讯
新帖
简况
股市必读:普蕊斯(301257)股东户数0.95万户,较上期增加40.85%
证券之星 · 02-03
股市必读:普蕊斯(301257)股东户数0.95万户,较上期增加40.85%
1月30日普蕊斯涨6.59%,诺安先锋混合A基金重仓该股
证券之星 · 01-30
1月30日普蕊斯涨6.59%,诺安先锋混合A基金重仓该股
普蕊斯涨6.59%,太平洋二个月前给出“买入”评级
证券之星 · 01-30
普蕊斯涨6.59%,太平洋二个月前给出“买入”评级
股市必读:普蕊斯(301257)股东户数0.68万户,较上期减少18.42%
证券之星 · 01-26
股市必读:普蕊斯(301257)股东户数0.68万户,较上期减少18.42%
普蕊斯:截至2025年12月31日收盘,公司股东总数为6,759户
证券之星 · 01-23
普蕊斯:截至2025年12月31日收盘,公司股东总数为6,759户
普蕊斯:汇添富基金、财通资管等多家机构于1月6日调研我司
证券之星 · 01-19
普蕊斯:汇添富基金、财通资管等多家机构于1月6日调研我司
普蕊斯:截至2025年12月31日股东总数为6,759户
证券之星 · 01-15
普蕊斯:截至2025年12月31日股东总数为6,759户
1月14日普蕊斯(301257)龙虎榜数据:机构净买入7326.96万元(3日)
证券之星 · 01-14
1月14日普蕊斯(301257)龙虎榜数据:机构净买入7326.96万元(3日)
1月14日普蕊斯涨14.70%,天弘医疗健康混合A基金重仓该股
证券之星 · 01-14
1月14日普蕊斯涨14.70%,天弘医疗健康混合A基金重仓该股
普蕊斯涨14.70%,太平洋二个月前给出“买入”评级
证券之星 · 01-14
普蕊斯涨14.70%,太平洋二个月前给出“买入”评级
千亿出海+天价猴!CRO板块扎堆涨停,这波红利能吃到2026?
中金财经 · 01-13
千亿出海+天价猴!CRO板块扎堆涨停,这波红利能吃到2026?
异动快报:普蕊斯(301257)1月13日9点47分触及涨停板
证券之星 · 01-13
异动快报:普蕊斯(301257)1月13日9点47分触及涨停板
股市必读:普蕊斯(301257)股东户数0.68万户,较上期减少18.42%
证券之星 · 01-13
股市必读:普蕊斯(301257)股东户数0.68万户,较上期减少18.42%
中邮证券:首次覆盖普蕊斯给予买入评级
证券之星 · 01-12
中邮证券:首次覆盖普蕊斯给予买入评级
1月8日普蕊斯涨7.57%,天弘医疗健康混合A基金重仓该股
证券之星 · 01-08
1月8日普蕊斯涨7.57%,天弘医疗健康混合A基金重仓该股
普蕊斯涨7.57%,太平洋二个月前给出“买入”评级
证券之星 · 01-08
普蕊斯涨7.57%,太平洋二个月前给出“买入”评级
股市必读:普蕊斯(301257)1月6日董秘有最新回复
证券之星 · 01-07
股市必读:普蕊斯(301257)1月6日董秘有最新回复
普蕊斯:截至2025年12月31日股东总数为6,759户
证券之星 · 01-05
普蕊斯:截至2025年12月31日股东总数为6,759户
1月5日普蕊斯涨6.17%,天弘医疗健康混合A基金重仓该股
证券之星 · 01-05
1月5日普蕊斯涨6.17%,天弘医疗健康混合A基金重仓该股
普蕊斯涨6.17%,太平洋二个月前给出“买入”评级
证券之星 · 01-05
普蕊斯涨6.17%,太平洋二个月前给出“买入”评级
加载更多
公司概况
公司名称:
普蕊斯(上海)医药科技开发股份有限公司
所属行业:
研究和试验发展
上市日期:
2022-05-17
主营业务:
普蕊斯(上海)医药科技开发股份有限公司的主营业务是向国内外制药公司、医疗器械公司及部分健康相关产品的临床研究开发提供SMO服务。公司的主要产品是试验管理、GCP培训、GCP资质申请、中心推广、第三方稽查、技术体系搭建、机构管理、数据库服务、患者招募、FSP服务、数据建模/培训、第三方稽查、中心快速启动、患者招募、第三方稽查、中心可行性调研、协助患者入组随访。公司荣获国家知识产权局授予的两项发明专利:“一种不良事件等级判定方法、电子设备和存储介质”和“基于数据库的多中心协同执行项目质量监控系统”。这两项发明专利均为公司自主研发与设计取得。前者所涉及的技术显著提升了不良事件处理的效率与准确性,优化数据录入,是公司核心技术的重要延伸;后者所涉及的技术作为公司服务质量控制的核心,进一步增强项目质量监控的精确性与实时性,保障临床试验质量符合高标准高要求。凭借以上两项技术,公司为客户交付高质量的临床试验服务,彰显了公司技术领域的领先地位与持续创新的能力。
发行价格:
46.80
{"stockData":{"symbol":"301257","market":"SZ","secType":"STK","nameCN":"普蕊斯","latestPrice":71.64,"timestamp":1770609093000,"preClose":69.35,"halted":0,"volume":1456230,"delay":0,"changeRate":0.033,"floatShares":75318900,"shares":79004800,"eps":1.5385,"marketStatus":"午间休市","change":2.29,"latestTime":"02-09 11:30:00","open":69.35,"high":72.43,"low":68.59,"amount":103000000,"amplitude":0.0554,"askPrice":71.62,"askSize":4,"bidPrice":71.43,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.5385,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770613200000},"marketStatusCode":3,"adr":0,"adjPreClose":69.35,"symbolType":"stock","openAndCloseTimeList":[[1770600600000,1770607800000],[1770613200000,1770620400000]],"highLimit":76.29,"lowLimit":62.42,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":79004770,"isCdr":false,"pbRate":4.37,"roa":"--","peRate":46.564836,"roe":"7.2%","epsLYR":1.35,"committee":-0.357143,"marketValue":5660000000,"turnoverRate":0.0193,"status":0,"floatMarketCap":5396000000},"requestUrl":"/m/hq/s/301257","defaultTab":"news","newsList":[{"id":"2608894580","title":"股市必读:普蕊斯(301257)股东户数0.95万户,较上期增加40.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608894580","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608894580?lang=zh_cn&edition=full","pubTime":"2026-02-03 02:42","pubTimestamp":1770057731,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘,普蕊斯报收于68.64元,下跌1.51%,换手率3.43%,成交量2.58万手,成交额1.79亿元。股本股东变化股东户数变动近日普蕊斯披露,截至2026年1月30日公司股东户数为9520.0户,较12月31日增加2761.0户,增幅为40.85%。户均持股数量由上期的1.17万股减少至8299.0股,户均持股市值为57.83万元。董秘最新回复投资者: 你好,公司截止1月30日最新的股东人数是多少?董秘: 尊敬的投资者您好,截至2026年1月30日收盘,公司股东总数为9,520户,感谢您的关注!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300001602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","BK0216"],"gpt_icon":0},{"id":"2607090131","title":"1月30日普蕊斯涨6.59%,诺安先锋混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2607090131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607090131?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:43","pubTimestamp":1769762633,"startTime":"0","endTime":"0","summary":"证券之星消息,1月30日普蕊斯涨6.59%,收盘报69.69元,换手率6.0%,成交量4.52万手,成交额3.11亿元。重仓普蕊斯的前十大公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级2家,增持评级2家;过去90天内机构目标均价为93.0。根据2025基金年报公募基金重仓股数据,重仓该股的公募基金共19家,其中持有数量最多的公募基金为诺安基金的诺安先锋混合A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000028066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2607901230","title":"普蕊斯涨6.59%,太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2607901230","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607901230?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:43","pubTimestamp":1769762621,"startTime":"0","endTime":"0","summary":"今日普蕊斯涨6.59%,收盘报69.69元。2025年11月1日,太平洋研究员周豫,张崴发布了对普蕊斯的研报《Q3业绩超预期,需求有望持续好转》,该研报对普蕊斯给出“买入”评级。研报中预计2025年-2027年公司营收为8.28/9.50/11.07亿元,同比增长3.02%/14.72%/16.57%;归母净利为1.28/1.44/1.64亿元,对应PE为32/29/25倍,持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为67.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000028063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301257"],"gpt_icon":0},{"id":"2606694265","title":"股市必读:普蕊斯(301257)股东户数0.68万户,较上期减少18.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606694265","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606694265?lang=zh_cn&edition=full","pubTime":"2026-01-26 03:11","pubTimestamp":1769368271,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,普蕊斯报收于68.15元,上涨1.73%,换手率3.63%,成交量2.73万手,成交额1.87亿元。股本股东变化股东户数变动近日普蕊斯披露,截至2025年12月31日公司股东户数为6759.0户,较11月28日减少1526.0户,减幅为18.42%。户均持股数量由上期的9536.0股增加至1.17万股,户均持股市值为60.83万元。董秘最新回复投资者: 你好,请问截至2026年1月20日,贵公司股东户数是多少?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2605242086","title":"普蕊斯:截至2025年12月31日收盘,公司股东总数为6,759户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605242086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605242086?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:18","pubTimestamp":1769156317,"startTime":"0","endTime":"0","summary":"证券之星消息,普蕊斯(301257)01月23日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,请问截至2026年1月20日,贵公司股东户数是多少?普蕊斯回复:尊敬的投资者您好,截至2025年12月31日收盘,公司股东总数为6,759户,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300022826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2604909990","title":"普蕊斯:汇添富基金、财通资管等多家机构于1月6日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2604909990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604909990?lang=zh_cn&edition=full","pubTime":"2026-01-19 10:33","pubTimestamp":1768790035,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年1月16日普蕊斯发布公告称汇添富基金、财通资管、农银汇理、中邮证券、华泰证券、华创证券、东方证券、国联民生证券、招商证券、华夏基金、万家基金、信达澳亚基金、慎知资产、人保养老、建投基金、华泰保兴基金、太平洋保险于2026年1月6日调研我司。普蕊斯主营业务:临床试验现场管理服务。该股最近90天内共有5家机构给出评级,买入评级4家,增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900007322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2603467914","title":"普蕊斯:截至2025年12月31日股东总数为6,759户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603467914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603467914?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:04","pubTimestamp":1768460657,"startTime":"0","endTime":"0","summary":"证券之星消息,普蕊斯(301257)01月15日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,请问截至2026年1月10日,贵公司股东户数是多少?普蕊斯回复:尊敬的投资者您好,截至2025年12月31日收盘,公司股东总数为6,759户,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500019285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2603388691","title":"1月14日普蕊斯(301257)龙虎榜数据:机构净买入7326.96万元(3日)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603388691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603388691?lang=zh_cn&edition=full","pubTime":"2026-01-14 17:31","pubTimestamp":1768383095,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2026年1月14日公布的交易公开信息显示,普蕊斯因连续三个交易日内,涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年1月14日收盘,普蕊斯报收于82.86元,上涨14.7%,换手率14.52%,成交量10.94万手,成交额8.7亿元。从龙虎榜公布的三日买卖数据来看,机构合计净买入7326.96万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400029666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2603069863","title":"1月14日普蕊斯涨14.70%,天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603069863","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603069863?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:41","pubTimestamp":1768376509,"startTime":"0","endTime":"0","summary":"证券之星消息,1月14日普蕊斯涨14.70%创60日新高,收盘报82.86元,换手率14.52%,成交量10.94万手,成交额8.7亿元。重仓普蕊斯的公募基金请见下表:该股最近90天内共有5家机构给出评级,买入评级4家,增持评级1家。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.63亿元,最新净值1.8712,较上一交易日上涨2.27%,近一年下跌6.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400020777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","BK0216","159760"],"gpt_icon":0},{"id":"2603698613","title":"普蕊斯涨14.70%,太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2603698613","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603698613?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:41","pubTimestamp":1768376499,"startTime":"0","endTime":"0","summary":"今日普蕊斯涨14.70%,收盘报82.86元。2025年11月1日,太平洋研究员周豫,张崴发布了对普蕊斯的研报《Q3业绩超预期,需求有望持续好转》,该研报对普蕊斯给出“买入”评级。研报中预计2025年-2027年公司营收为8.28/9.50/11.07亿元,同比增长3.02%/14.72%/16.57%;归母净利为1.28/1.44/1.64亿元,对应PE为32/29/25倍,持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为67.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400020772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301257"],"gpt_icon":0},{"id":"2603750260","title":"千亿出海+天价猴!CRO板块扎堆涨停,这波红利能吃到2026?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603750260","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603750260?lang=zh_cn&edition=full","pubTime":"2026-01-13 17:30","pubTimestamp":1768296601,"startTime":"0","endTime":"0","summary":"据悉,2025年国内创新药BD出海金额突破1000亿美元,2026年预期加速,CRO企业作为研发外包核心服务商直接受益于订单放量。另外,2025年12月,广东、广西等地猴场实验猴已订至2026年上半年,供不应求局面持续,推动CRO企业战略资源溢价。一猴难求除了创新药出海带来的订单红利,实验猴资源的稀缺性进一步推升了CRO企业的战略价值。机构看好企业发展前景机构普遍看好CRO板块2026年的发展前景。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/13/20260113553813.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260113/31938136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["301060","BK0236","301333","BK1574","BK0114","300404","300244","BK0042","BK0186","BK0070","BK0028","BK0146","BK0197","688137","BK0216","301257","BK1161","06978","301230"],"gpt_icon":0},{"id":"2603573083","title":"异动快报:普蕊斯(301257)1月13日9点47分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2603573083","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603573083?lang=zh_cn&edition=full","pubTime":"2026-01-13 09:50","pubTimestamp":1768269043,"startTime":"0","endTime":"0","summary":"证券之星1月13日盘中消息,9点47分普蕊斯触及涨停板。其所属行业医疗服务目前上涨。领涨股为泓博医药。该股为减肥药,肝炎概念,CAR-T疗法概念热股,当日减肥药概念上涨2.61%,肝炎概念概念上涨2.42%,CAR-T疗法概念上涨1.51%。1月12日的资金流向数据方面,主力资金净流入19.43万元,占总成交额0.21%,游资资金净流出10.72万元,占总成交额0.12%,散户资金净流出8.7万元,占总成交额0.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300009567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2603152365","title":"股市必读:普蕊斯(301257)股东户数0.68万户,较上期减少18.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603152365","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603152365?lang=zh_cn&edition=full","pubTime":"2026-01-13 03:19","pubTimestamp":1768245549,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘,普蕊斯报收于60.2元,上涨0.1%,换手率2.01%,成交量1.51万手,成交额9047.07万元。股本股东变化股东户数变动近日普蕊斯披露,截至2025年12月31日公司股东户数为6759.0户,较11月28日减少1526.0户,减幅为18.42%。户均持股数量由上期的9536.0股增加至1.17万股,户均持股市值为60.83万元。董秘最新回复投资者: 你好 请问截止2026年1月9日公司股东人数多少?董秘: 尊敬的投资者您好,截至2025年12月31日收盘,公司股东总数为6,759户,感谢您的关注!","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300003246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2602886516","title":"中邮证券:首次覆盖普蕊斯给予买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2602886516","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602886516?lang=zh_cn&edition=full","pubTime":"2026-01-12 18:37","pubTimestamp":1768214231,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,陈灿近期对普蕊斯进行研究并发布了研究报告《Q3收入增速稳定,毛利率显著回暖》,首次覆盖普蕊斯给予买入评级。公司为国内SMO行业领导企业之一,考虑国内创新药投融资有望于26年进一步回暖,首次覆盖,给予“买入”评级。最新盈利预测明细如下:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200027319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301257"],"gpt_icon":0},{"id":"2601356141","title":"1月8日普蕊斯涨7.57%,天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356141","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356141?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:41","pubTimestamp":1767858092,"startTime":"0","endTime":"0","summary":"证券之星消息,1月8日普蕊斯涨7.57%创60日新高,收盘报61.1元,换手率3.53%,成交量2.66万手,成交额1.58亿元。重仓普蕊斯的公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.63亿元,最新净值1.7894,较上一交易日上涨3.28%,近一年下跌6.15%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","159760","301257"],"gpt_icon":0},{"id":"2601356497","title":"普蕊斯涨7.57%,太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601356497","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601356497?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:41","pubTimestamp":1767858083,"startTime":"0","endTime":"0","summary":"今日普蕊斯涨7.57%,收盘报61.1元。2025年11月1日,太平洋研究员周豫,张崴发布了对普蕊斯的研报《Q3业绩超预期,需求有望持续好转》,该研报对普蕊斯给出“买入”评级。研报中预计2025年-2027年公司营收为8.28/9.50/11.07亿元,同比增长3.02%/14.72%/16.57%;归母净利为1.28/1.44/1.64亿元,对应PE为32/29/25倍,持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为67.97%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301257"],"gpt_icon":0},{"id":"2601084818","title":"股市必读:普蕊斯(301257)1月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601084818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601084818?lang=zh_cn&edition=full","pubTime":"2026-01-07 04:45","pubTimestamp":1767732312,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘,普蕊斯报收于54.0元,下跌2.26%,换手率1.91%,成交量1.44万手,成交额7740.12万元。董秘最新回复投资者: 你好 请问截止2025年12月31日 公司股东人数多少?谢谢董秘: 尊敬的投资者您好,截至2025年12月31日收盘,公司股东总数为6,759户,感谢您的关注!交易信息汇总资金流向1月6日主力资金净流入8.43万元;游资资金净流入25.17万元;散户资金净流出33.59万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700002048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301257","BK0216"],"gpt_icon":0},{"id":"2601046990","title":"普蕊斯:截至2025年12月31日股东总数为6,759户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601046990","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601046990?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:01","pubTimestamp":1767603662,"startTime":"0","endTime":"0","summary":"证券之星消息,普蕊斯(301257)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘,您好!请问公司截至12月31日的股东人数是多少?谢谢普蕊斯回复:尊敬的投资者您好,截至2025年12月31日收盘,公司股东总数为6,759户,感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500023484.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301257"],"gpt_icon":0},{"id":"2601500653","title":"1月5日普蕊斯涨6.17%,天弘医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601500653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601500653?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:47","pubTimestamp":1767599228,"startTime":"0","endTime":"0","summary":"证券之星消息,1月5日普蕊斯涨6.17%创60日新高,收盘报55.25元,换手率2.96%,成交量2.23万手,成交额1.22亿元。重仓普蕊斯的公募基金请见下表:该股最近90天内共有4家机构给出评级,买入评级3家,增持评级1家。根据2025基金Q3季报公募基金重仓股数据,重仓该股的公募基金共9家,其中持有数量最多的公募基金为天弘基金的天弘医疗健康混合A。天弘医疗健康混合A目前规模为2.63亿元,最新净值1.6401,较上一交易日下跌0.25%,近一年下跌6.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0216","301257"],"gpt_icon":0},{"id":"2601006310","title":"普蕊斯涨6.17%,太平洋二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2601006310","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601006310?lang=zh_cn&edition=full","pubTime":"2026-01-05 15:46","pubTimestamp":1767599218,"startTime":"0","endTime":"0","summary":"今日普蕊斯涨6.17%,收盘报55.25元。2025年11月1日,太平洋研究员周豫,张崴发布了对普蕊斯的研报《Q3业绩超预期,需求有望持续好转》,该研报对普蕊斯给出“买入”评级。研报中预计2025年-2027年公司营收为8.28/9.50/11.07亿元,同比增长3.02%/14.72%/16.57%;归母净利为1.28/1.44/1.64亿元,对应PE为32/29/25倍,持续给予“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为67.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500015853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","301257"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770609124221,"stockEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.221},{"period":"3month","weight":0.4674},{"period":"6month","weight":0.8068},{"period":"1year","weight":1.5388},{"period":"ytd","weight":0.3326}],"compareEarnings":[{"period":"1week","weight":-0.0127},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.017},{"period":"6month","weight":0.1184},{"period":"1year","weight":0.243},{"period":"ytd","weight":0.0244}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"普蕊斯(上海)医药科技开发股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"9520人(较上一季度增加40.85%)","perCapita":"7911股","listingDate":"2022-05-17","address":"上海市黄浦区思南路105号1号楼108室","registeredCapital":"7900万元","survey":" 普蕊斯(上海)医药科技开发股份有限公司的主营业务是向国内外制药公司、医疗器械公司及部分健康相关产品的临床研究开发提供SMO服务。公司的主要产品是试验管理、GCP培训、GCP资质申请、中心推广、第三方稽查、技术体系搭建、机构管理、数据库服务、患者招募、FSP服务、数据建模/培训、第三方稽查、中心快速启动、患者招募、第三方稽查、中心可行性调研、协助患者入组随访。公司荣获国家知识产权局授予的两项发明专利:“一种不良事件等级判定方法、电子设备和存储介质”和“基于数据库的多中心协同执行项目质量监控系统”。这两项发明专利均为公司自主研发与设计取得。前者所涉及的技术显著提升了不良事件处理的效率与准确性,优化数据录入,是公司核心技术的重要延伸;后者所涉及的技术作为公司服务质量控制的核心,进一步增强项目质量监控的精确性与实时性,保障临床试验质量符合高标准高要求。凭借以上两项技术,公司为客户交付高质量的临床试验服务,彰显了公司技术领域的领先地位与持续创新的能力。","listedPrice":46.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"普蕊斯(301257)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供普蕊斯(301257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"普蕊斯,301257,普蕊斯股票,普蕊斯股票老虎,普蕊斯股票老虎国际,普蕊斯行情,普蕊斯股票行情,普蕊斯股价,普蕊斯股市,普蕊斯股票价格,普蕊斯股票交易,普蕊斯股票购买,普蕊斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"普蕊斯(301257)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供普蕊斯(301257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}